Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in the circulating cell-free DNA (ccfDNA) diagnostics market.

Brooklyn, New York, June 22, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is projected to grow from USD 4.9 billion in 2022 to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027.

Growing concern for early cancer detection is one of the key drivers of the Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market. Other drivers include the success of NIPTs, rising cancer prevalence, and an increase in R&D programs to explore the potential of circulating biomarkers in disease diagnosis.

Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market - Forecast to 2027’’

Key Market Insights

• As per the end-use outlook, the hospitals & prenatal clinics segment is expected to be the largest segment in the 2021 circulating cell-free DNA (ccfDNA) diagnostics market
• As per the application type, the non-invasive prenatal testing segment is expected to be the largest segment in the circulating cell-free DNA (ccfDNA) diagnostics market from 2022 to 2027
• The United States will have the largest share in the market during the forecast period of 2022-2027
• Asia Pacific is anticipated to be the fastest-growing region in the market
• Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in the circulating cell-free DNA (ccfDNA) diagnostics market
  
  

Request a Sample Copy of the report @ https://www.globalmarketestimates.com/market-report/circulating-cell-free-dna-ccfdna-diagnostics-market-3851

Application Outlook (Revenue, USD Billion, 2022-2027)

• Non-invasive Prenatal Testing
• Cancer Diagnostics
• Others
  
  

Type Outlook (Revenue, USD Billion, 2022-2027)

• Hospitals & Prenatal Clinics
• Diagnostic Centers
• Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America        

• The U.S.
• Canada
• Mexico
  

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA
  

Middle East & Africa

• Saudi Arabia
• South Africa
• Rest of MEA
  
  

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +1 6026667238

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +1 6026667238

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.